Ashwagandha has moved from Ayurvedic pharmacy shelves to mainstream stress and sleep supplements in under a decade, and India supplies almost all of it. This briefing is written from the supplier’s side of the desk: where the demand is, how the root reaches the extraction plant, and why two quotes for “5% ashwagandha” can be far apart.
Demand: where the volume is
Four applications carry most of the volume. Stress and sleep supplements in North America and Europe remain the anchor, usually as capsules and gummies. Sports and active nutrition uses ashwagandha for recovery and strength positioning. Functional beverages and powders — lattes, shots, adaptogen blends — are the fastest-growing format, and the one that pushes demand toward water-soluble and higher grades. India’s own market, traditional and modern, is large and price-sensitive. Asia-Pacific supplement markets, Thailand and Vietnam among them, are growing from a small base and buy on documentation as much as on price.
Supply: root, belts and calendar
Cultivated ashwagandha comes mainly from Madhya Pradesh (the Neemuch and Mandsaur belt is the historic centre, with the prized Nagori root), Rajasthan and parts of Gujarat and Maharashtra. It is a rain-fed, short-duration crop: sown after the monsoon, harvested from roughly January to March, when the root is dug, washed, cut and sun-dried. Extraction plants buy dried root through the year against that single harvest, so root prices are set in the first quarter and drift after it. A weak monsoon or a shift of acreage to a competing crop shows up in extract quotes within months.
Branded and generic
The market splits into branded extracts with clinical dossiers and licensed marks, and generic standardised extracts sold on specification. Branded ingredients dominate the premium hero-SKU segment; generics carry blends, private label, traditional formats and most of the volume. The comparison is drawn out in branded versus generic ashwagandha. For a supplier the practical effect is that generic buyers increasingly write branded-quality specifications: root only, HPLC method, withaferin A cap, residue panel.
Regulatory headwinds in Europe
Ashwagandha’s safety profile has been questioned by some European authorities. Denmark prohibited it in food supplements after a national risk assessment, and other member states have issued advice or opened reviews; positions differ country by country and change. The consequence for buyers is that the EU is not one market for this ingredient: destination-country status has to be checked at the time of formulation, and the documentation burden (residue panel, ethylene oxide, heavy metals, plant part declared) is higher than for most botanicals. Our regulatory and compliance guide covers the paperwork; the country status list should be verified against the current instrument on the day, not taken from any article, this one included.
What moves the price
- Root price after harvest — the largest single input, set by monsoon, acreage and demand from the domestic Ayurvedic industry.
- Grade and method — a 10% HPLC grade consumes far more root per kilogram than a 2.5% gravimetric grade.
- Plant part — root-only material costs more than root-and-leaf.
- Residue and documentation row — an EU-row lot with pesticide, ETO and PAH testing carries the testing cost and the yield loss of rejected lots.
- Volume and terms — 100, 250 and 500 kg price differently, as does EXW against CIF.
What a buyer can do about it
Buy against a specification, not a name; ask for two grades on the same assay basis; quote at three volumes; and time larger purchases after the harvest when the root price is known. SV Botanica quotes in exactly that structure, with a published COA and specification so the comparison starts from documents.
Quote Ashwagandha Extract at 100, 250 and 500 kg
Standard and EU-row grades, EXW / FOB / CIF, documents up front.